Sweden: Eir Ventures I life sciences VC fund closes at €122.3m

Eir Ventures, a Nordic Life Science Venture Capital manager, has closed Eir Ventures I at €122.3m (US$137.8m) . The fund is the firm’s first dedicated life sciences venture capital fund. It was launched in 2020 with support from a syndicate comprising the European Investment Fund (EIF), Novo Holdings, Saminvest, Vækstfonden, as well as a group…

You must be a HMI Subscriber to view this content.

Subscribe Now »